A Day Up For Elevation Oncology Inc.
Thu, Feb 23, 2023 at 07:12 PM
Elevation Oncology Inc. (ELEV:NASDAQ) rocketted at $1.26, a gain of 27.3%. On Thu, Feb 23, 2023, ELEV:NASDAQ hit a New 2-Week High of $1.26. The stock got featured on our News Catalysts scanner on Wed, Feb 08, 2023 at 07:45 AM in the 'MISCELLANEOUS' category. From Thu, Feb 09, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 124.53%
- Genesis Growth Tech Acquisition Corp. (GGAA:NASDAQ), 63.94%
- Atlas Lithium Corporation (ATLX:NASDAQ), 60.47%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 43.2%
- Expion360 Inc. (XPON:NASDAQ), 42.39%
- Applied Molecular Transport Inc. (AMTI:NASDAQ), 34.69%
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 32.91%
- Vascular Biogenics Ltd. (VBLT:NASDAQ), 29.46%
- Verde Clean Fuels Cl A (VGAS:NASDAQ), 28.15%
- Elevation Oncology Inc. (ELEV:NASDAQ), 27.27%